Endymed (Israel) Top Management
ENDY Stock | 324.90 2.10 0.65% |
Endymed employs about 41 people. The company is managed by 37 executives with a total tenure of roughly 256 years, averaging almost 6.0 years of service per executive, having 1.11 employees per reported executive. Analysis of Endymed's management performance can provide insight into the company performance.
Yoram Hert CEO CEO, Endymed Medical Ltd. |
Amy Kamin CEO CEO of EndyMed USA |
Endymed |
Endymed Management Team Effectiveness
The company has return on total asset (ROA) of 0.0385 % which means that it generated a profit of $0.0385 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2146 %, meaning that it generated $0.2146 on every $100 dollars invested by stockholders. Endymed's management efficiency ratios could be used to measure how well Endymed manages its routine affairs as well as how well it operates its assets and liabilities.Endymed Workforce Comparison
Endymed is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 114. Endymed totals roughly 41.0 in number of employees claiming about 36% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Endymed Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Endymed Price Series Summation is a cross summation of Endymed price series and its benchmark/peer.
Endymed Notable Stakeholders
An Endymed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Endymed often face trade-offs trying to please all of them. Endymed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Endymed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel Lischinsky | Founder and VP of RandD | Profile | |
Yoram Hert | CEO, Endymed Medical Ltd. | Profile | |
Amy Kamin | CEO of EndyMed USA | Profile | |
Elad Magal | CEO | Profile | |
Yosef BarOn | CEO | Profile | |
Amir Schori | Vice President - Business Development | Profile | |
Rami Aviram | Vice President - Finance | Profile | |
Sima Witman | Vice President - Research & Development | Profile | |
Oren Maymon | Vice President - Operations | Profile | |
Lior Cohen | Vice President of Sales | Profile | |
Atzmon Shlush | Vice President - Operations | Profile | |
Eran Ishay | Vice President - Research & Development | Profile | |
Daniel Lishinsky | Vice President - Research & Development | Profile | |
Zvika Lifschitz | Vice President - Finance | Profile | |
Ben Feldman | CFO | Profile | |
Amiram Goldman | External Director | Profile | |
Eran Naor | External Director, Independent Director | Profile | |
Ronen Zadok | External Director | Profile | |
Yoram Harth | Founder, Director & Chief Medical Officer | Profile | |
Yuan Yibing | Director | Profile | |
Batsheva Elran | Director | Profile | |
Jan Jingran | Director | Profile | |
Sharon Dovev | Director of Marketing | Profile | |
Lior Vider | External Director | Profile | |
Idan Alfa | Finance Director | Profile | |
Yocheved Dvir | Director | Profile | |
Annie Jin | Director | Profile | |
Lee Roth | Finance Director | Profile | |
Ofer Zvi | Director | Profile | |
Lee Gabay | Controller | Profile | |
Yossi CPA | Chief Officer | Profile | |
Sima Weissman | VP RD | Profile | |
Joseph Levtzler | Clinical VP | Profile | |
Bill Scott | Pres Inc | Profile | |
Moshe Cohen | Internal Auditor | Profile | |
Frank Iannelli | Corporate Executive | Profile | |
Amir Ganun | VP Marketing | Profile |
About Endymed Management Performance
The success or failure of an entity such as Endymed often depends on how effective the management is. Endymed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Endymed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Endymed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.
The data published in Endymed's official financial statements usually reflect Endymed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Endymed. For example, before you start analyzing numbers published by Endymed accountants, it's critical to develop an understanding of what Endymed's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Endymed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Endymed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Endymed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Endymed. Please utilize our Beneish M Score to check the likelihood of Endymed's management manipulating its earnings.
Endymed Workforce Analysis
Traditionally, organizations such as Endymed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Endymed within its industry.Endymed Manpower Efficiency
Return on Endymed Manpower
Revenue Per Employee | 531.3K | |
Revenue Per Executive | 588.7K | |
Net Income Per Employee | 125.9K | |
Net Income Per Executive | 139.5K | |
Working Capital Per Employee | 122K | |
Working Capital Per Executive | 135.1K |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Endymed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Endymed Stock analysis
When running Endymed's price analysis, check to measure Endymed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endymed is operating at the current time. Most of Endymed's value examination focuses on studying past and present price action to predict the probability of Endymed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endymed's price. Additionally, you may evaluate how the addition of Endymed to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |